Trapidil-mediated inhibition of CNS remyelination results from reduced numbers and impaired differentiation of oligodendrocytes

Neuropathology and Applied Neurobiology

Volumn 24, Issue 6, 1998, Pages 498-506

  McKay, J S ^a,c   Blakemore, W F ^a   Franklin, R J M ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

CNS; Demyelination; Growth factor; Lysolecithin; Remyelination; Trapidil

Indexed keywords

GROWTH FACTOR; LYSOPHOSPHATIDYLCHOLINE; MYELIN; TRAPIDIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DRUG EFFECT; ELECTRON MICROSCOPY; INTRAPERITONEAL DRUG ADMINISTRATION; MICROGLIA; MYELIN SHEATH; NERVE CELL DIFFERENTIATION; NERVE FIBER; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; RAT; REMYELINIZATION; SPINAL CORD;

ANIMALS; CELL COUNT; CELL DIFFERENTIATION; FEMALE; GROWTH INHIBITORS; GROWTH SUBSTANCES; MYELIN SHEATH; NERVE REGENERATION; OLIGODENDROGLIA; PHENOTYPE; RATS; TRAPIDIL;

EID: 0032436444     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1998.00148.x     Document Type: Article

References (52)

1. Armstrong RC, Harvath L, Dubois-Dalcq ME. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J Neurosci Res 1990; 27: 400-7
2. Barres BA, Hart IK, Coles HSR et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992; 70: 31-46
3. Benveniste EN, Merrill JE. Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature 1986; 321: 610-3
4. Bignami A, Ralston HJ. The cellular reaction to Wallerian degeneration in the central nervous system of the cat. Brain Res 1969; 13: 444-61
5. Blakemore WF. Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J Neurol Sci 1973; 20: 63-72
6. Blakemore WF. Myelination, demyelination and remyelination in the CNS. In Recent Advances in Neuropathology 2. Thomas-Smith W. and Cavanagh J.B., Eds. Edinburgh: Churchill Livingstone, 1982: 53-81
7. Bogler O, Wren D, Barnett SC, Land H, Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci USA 1990; 87: 6368-72
8. Canoll PD, Musacchio JM, Hardy R, Reynolds R, Marchionni MA, Salzer JL. GGF/Neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 1996; 17: 229-43
9. Carroll WM, Jennings AR, Mastaglia FL. The origin of remyelinating oligodendrocytes in antiserum-mediated demyelinative optic neuropathy. Brain 1990; 113: 953-73
10. Carroll WM, Jennings AR. Early recruitment of oligodendrocyte precursors in CNS demyelination. Brain 1994; 117: 563-78
11. Engel U, Wolswijk G. Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells derived from adult rat spinal cord: in vitro characteristics and response to PDGF, bFGF and NT-3. Glia 1996; 16: 16-26
12. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-9
13. Fressinaud C, Vallat J-M, Pouplard-Barthelaix A. Platelet-derived growth factor partly prevents chemically induced oligodendrocyte death and improves myelin-llke membranes repair in vitro. Glia 1996; 16: 40-50
14. Gard AL, Pfeiffer SE. Glial cell mitogens bFGF and PDGF differentially regulate development of 04 + GalC-oligodendrocyte progenitors. Dev Biol 1993; 159: 618-30
15. Gensert JM, Goldman JE. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 1997; 19: 197-203
16. Gesualdo L, DI Paolo S, Ranieri E, Schena FP. Trapidil inhibits human mesangial cell proliferation: effect on PDGF, 1994
17. Giulian D, Baker TJ, Shih L-CN, Lachmann LB. Interleukin-1 of the central nervous system is produced by amoeboid microglia. J Exp Med 1986; 164: 584-604
18. George J, Rutecki PA. The impact of microglia-derived cytokines upon gliosis in the CNS. Dev Neurosci 1994a; 16: 128-36
19. Godfraind C, Friedrich VL, Holmes KV, Dubois-Dalcq M. In vivo analysis of glial cell phenotypes during a viral demyelinating disase in mice. J Cell Biol 1989; 109: 2405-16
20. Grinspan J, Wrabetz L, Kamholz J. Oligodendrocyte maturation and myelin gene expression in PDGF-treated cultures from rat cerebral white matter. J Neurocytol 1993; 22: 322-33
21. Hart IK, Richardson WD, Heldin C-H, Westermark B, Raff MC. PDGF receptors on cells of the oligodendrocyte-type-2 astrocyte (O-2A) cell lineage. Development 1989; 105: 595-603
22. Kierstead HS, Blakemore WF. Post-mitotic oligodendrocytes do not remyelinate. J Neuropath Exp Neurol 1997; 56: 1191-201
23. Kierstead HS, Blakemore WF. The response of the oligodendrocyte progenitor cell population (as defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 1998; 22: 161-70
24. Komoly S, Hudson LD, Webster H, deF, Bondy CA. Insulin-like growth factor 1 gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci USA 1992; 89: 1894-8
25. Kruger L, Maxwell DS. Electron microscopy of oligodendrocytes in normal rat cerebrum. Am J Anat 1966; 118: 411-36
26. Ling EA, Paterson JA, Privat A, Mori S, Leblond CP. Investigation of glial cells in semithin sections: identification of glial cells in the brain of young rats. J Comp Neurol 1972; 149: 43-72
27. Ludwin SK. An autoradiographic study of cellular proliferation in remyelination of the central nervous system. Am J Path 1979; 95: 683-96
28. Ludwin SK. Remyelination in demyelinating diseases of the central nervous system. CRC Critical Reviews in Neurobiology 1987; 3: 1-28
29. Ludwin SK. Oligodendrocyte survival in Wallerian degeneration. Acta Neuropathol 1990; 80: 184-91
30. McKay JS, Blakemore WF, Franklin RJM. (1997) The effects of the growth factor-antagonist, trapidil, on remyelination in the CNS. Neuropathol Appl Neurobiol 1997; 23: 50-8
31. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 1990; 5: 603-14
32. McMorris FA, Dubois-Dalcq M. Insulin-like growth factor 1 promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J Neurosci Res 1988; 21: 199-209
33. Milner R, Anderson HJ, Rippon RF et al. Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration. Glia 1997; 19: 85-90
34. Mori S, LeBlond CP. Identification of microglia in light and electron microscopy. J Comp Neurol 1969; 135: 57-80
35. Mori S, Leblond CP. Electron microscopic features and proliferation of astrocytes in the corpus callosum of the rat. J Comp Neurol 1969; 137: 197-226
36. Mori S, Leblond CP. Electron microscopic identification of three classes of oligodendrocytes and a preliminary study of their proliferative activity in the corpus callosum of young rats. J Comp Neurol 1970; 139: 1-30
37. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 1988; 333: 560-2
38. Ohnishi H, Yamaguchi K, Shimada S, Suzuki Y, Kumagai A. A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor. Life Sci 1981b; 28: 1641-6
39. Peters A, Palay SL, Webster H, DeF. The Fine Structure of the Nervous System. Oxford: Oxford University Press, 1991
40. Pollack IF, Randall MS, Kristolik MP, Kelly RH, Selker RG, Vertosick FT. Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways. J Neurosurg 1991; 75: 284-93
41. Prineas JW, Kwon EE, Goldenberg PZ et al.. Multiple sclerosis: oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 1989; 61: 489-503
42. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho E-S. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993; 33: 137-51
43. Raine CS, Wu E. Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol 1993; 52: 199-204
44. Reynolds R, Wilkin GP. (1993) Cellular reaction to an acute demyelinating/remyelinating lesion of the rat brain stem: localisation of GD3 ganglioside immunoreactivity. J Neurosci Res 1993; 36: 417-34
45. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M. A role for PDGF in normal gliogenesis in the central nervous system. Cell 1988; 53: 309-19
46. Robinson S, Miller R. (1996) Environmental enhancement of growth factor-mediated oligodendrocyte precursor proliferation. Molec Cell Neurosci 1996; 8: 38-52
47. Sawada M, Suzumura A, Marunouchi T. TNF induces IL-6 production by astrocytes but not by microglia. Brain Res 1992; 583: 296-9
48. Smith KJ. Conduction properties of central demyelinated and remyelinated axons, and their relation to symptom production in demyelinating disorders. Eye 1994; 8: 224-37
49. Todo T, Adams EF, Fahlbusch R. Inhibitory effect of trapidil on human meningioma cell proliferation via interruption of autocrine growth stimulation. J Neurosurg 1993; 78: 463-9
50. Tourbah A, Baron-Van Evercooren A, Oliver L, Raulais D, Jeanny JC, Cumpel M. Endogenous FGF expression and cellular changes after a demyelinating lesion in the spinal cord of adult normal mice: immunohistochemical study. J Neurosci Res 1992; 33: 47-59
51. Trapp B, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. New Eng J Med 1998; 338: 278-85
52. Woodruff RH, Franklin RJM. Growth factors and remyelination in the CNS. Histol Histopathol 1997; 12: 459-66